US 10265411
N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides
granted A61KA61K31/165A61K47/60
Quick answer
US patent 10265411 (N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides) held by Nektar Therapeutics expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Nektar Therapeutics
- Grant date
- Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/165, A61K47/60, A61P, A61P25/08